SPEAKERS
ARDD 2026
Leaders in the aging and longevity field will describe the latest progress in the molecular, cellular and organismal basis of aging and our search for interventions.
← Back to speakers
Stephanie Manson-Brown

Stephanie Manson-Brown

Vice President, Head of Clinical Development & Scientific Innovation and Skincare R&D · AbbVie
Dr. Stephanie Manson Brown is Vice President, Head of Clinical Development & Scientific Innovation and Skincare R&D at Allergan Aesthetics, AbbVie. Her Clinical Development and Scientific Innovation team are responsible for global clinical trial development strategy for the Aesthetic Medicine portfolio, covering pharmaceuticals and device; for developing innovative endpoint evaluation tools; bringing digital science and technology solutions to R&D programmes; and driving inclusion and diversity in the generation of data that is representative of individual needs. Her Skincare R&D team are responsible for developing an innovative product pipeline supported by robust scientific data and with a focus on aging science. She was honoured as a 2023 Healthcare Business Women’s (HBA) Luminary. Prior to joining industry, Stephanie was trained to be a Plastic Surgeon and is a board-certified surgeon (MRCS).